New Brunswick, NJ - Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference on Tuesday, June 8th. Mathai Mammen, Global Head, Research & Development Janssen Research Development will represent the Company in a session scheduled at 9:40 a.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48 hours after the live webcast.

Contact:

Press

Christina Chan

T: (732) 524-6297

Investor

Christopher DelOrefice

T: (732) 524-2955

Jennifer McIntyre

T: (732) 524-3922

(C) 2021 Electronic News Publishing, source ENP Newswire